Flynn James E's most recent trade in Larimar Therapeutics Inc was a trade of 3,387,539 Common Stock done at an average price of $3.2 . Disclosure was reported to the exchange on July 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Larimar Therapeutics Inc | Flynn E James | Director, Ten Percent Owner, * Director by Deputization | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 31 Jul 2025 | 3,387,539 | 9,538,945 | - | 3.2 | 10,840,125 | Common Stock |
| Larimar Therapeutics Inc | Flynn E James | Director, Ten Percent Owner, * Director by Deputization | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 31 Jul 2025 | 3,387,529 | 9,538,918 | - | 3.2 | 10,840,093 | Common Stock |
| Larimar Therapeutics Inc | Flynn E James | Director, Ten Percent Owner, * Director by Deputization | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 31 Jul 2025 | 2,599,932 | 7,321,129 | - | 3.2 | 8,319,782 | Common Stock |
| Larimar Therapeutics Inc | Flynn E James | Director, Ten Percent Owner, * Director by Deputization | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Larimar Therapeutics Inc | Flynn E James | Director, Ten Percent Owner, * Director by Deputization | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Larimar Therapeutics Inc | Flynn James E | Director, Ten Percent Owner, * Director by Deputization | Purchase of securities on an exchange or from another person at price $ 8.74 per share. | 16 Feb 2024 | 1,430,206 | 6,151,389 | - | 8.7 | 12,500,000 | Common Stock |
| Larimar Therapeutics Inc | James Flynn E | Director, Ten Percent Owner, * Director by Deputization | Purchase of securities on an exchange or from another person at price $ 8.74 per share. | 16 Feb 2024 | 1,430,206 | 6,151,406 | - | 8.7 | 12,500,000 | Common Stock |
| Larimar Therapeutics Inc | E Flynn James | Director, Ten Percent Owner, * Director by Deputization | Purchase of securities on an exchange or from another person at price $ 8.74 per share. | 16 Feb 2024 | 1,430,205 | 4,207,982 | - | 8.7 | 12,499,992 | Common Stock |
| Larimar Therapeutics Inc | Flynn James E | Director, Ten Percent Owner, * Director by Deputization | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 8,300 | 8,300 | - | - | Stock Option (Right to Buy) |